Akari Therapeutics announces 1-for-40 reverse split to address Nasdaq delisting risk
Filed March 17, 2026 · Period ending March 17, 2026 · ~1 min read
3 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade AKTX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 4, 2026 10:01 PM